摘要
研究参附注射液在胃癌术前介入化疗中的作用 ,将 87例进展期胃癌患者分成两组。分别检测T细胞亚群、白细胞总数及淋巴细胞数量等。结果 :参附组对CD3 、CD4,CD4/CD8的提高作用显著高于化疗组 ,且能保持白细胞及淋巴细胞的数量。提示参附注射液可增强胃癌术前介入化疗的患者的细胞免疫功能。
To study the effects of 'Shenfu Injection' on the interference of chemotherapy preceding gastric surgery, 87 cases were divided into two groups and the T lymphocyte subpopulation, total white blood cell and lymphocyte were measured. Results: In treatment group, CD 3, CD 4 and CD 4/CD 8 rose more significantly than those in control group, and the white blood cell and lymphocyte remained stable in number. It is indicated that 'Shenfu Injection' can boost the immunity.
出处
《上海中医药杂志》
北大核心
2004年第6期20-20,共1页
Shanghai Journal of Traditional Chinese Medicine
关键词
参附注射液
胃癌
化疗
Shenfu Injection'
gastric cancer
chemotherapy